Site-directed modification of FVIII
This invention relates to Factor VIII muteins that are covalently bound, at a predefined site that is not an N-terminal amine, to one or more biocompatible polymers such as polyethylene glycol. The mutein conjugates retain FVIII procoagulant activity and have improved pharmacokinetic properties.
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
07.09.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!